Zoliflodacin
≥98%
- Product Code: 64096
CAS:
1620458-09-4
Molecular Weight: | 487.44 g./mol | Molecular Formula: | C₂₂H₂₂FN₅O₇ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
Zoliflodacin is primarily used in the treatment of uncomplicated urogenital gonorrhea, a sexually transmitted infection caused by *Neisseria gonorrhoeae*. It is particularly valuable as it targets strains of the bacteria that have developed resistance to other antibiotics, such as cephalosporins. This makes it a critical option in addressing the growing challenge of antimicrobial resistance in gonorrhea treatment. Zoliflodacin works by inhibiting the bacterial DNA gyrase, an enzyme essential for DNA replication, thereby stopping the growth and spread of the bacteria. Its oral administration offers a convenient and effective treatment option, reducing the need for injectable antibiotics. Ongoing research is also exploring its potential use in treating other bacterial infections.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | solid |
PURITY | 97.5-100 |
Infrared spectrum | Conforms to Structure |
NMR | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | £905.00 |
+
-
|
0.010 | 10-20 days | £1,369.10 |
+
-
|
Zoliflodacin
Zoliflodacin is primarily used in the treatment of uncomplicated urogenital gonorrhea, a sexually transmitted infection caused by *Neisseria gonorrhoeae*. It is particularly valuable as it targets strains of the bacteria that have developed resistance to other antibiotics, such as cephalosporins. This makes it a critical option in addressing the growing challenge of antimicrobial resistance in gonorrhea treatment. Zoliflodacin works by inhibiting the bacterial DNA gyrase, an enzyme essential for DNA replication, thereby stopping the growth and spread of the bacteria. Its oral administration offers a convenient and effective treatment option, reducing the need for injectable antibiotics. Ongoing research is also exploring its potential use in treating other bacterial infections.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :